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Intravoxel IncoherentMotion Protocol Evaluation andData Quality
in Normal and Malignant Liver Tissue and Comparison
to the Literature
Edwin E.G.W. ter Voert, MSc,*† Gaspar Delso, PhD,‡ Miguel Porto, BSc,*†
Martin Huellner, MD,*†§ and Patrick Veit-Haibach, MD*†k
Objectives: Although intravoxel incoherent motion (IVIM) becomes more and
more popular, there is currently no clear consensus on the number and distribu-
tion of b-values to use. In this work, we (1) tested and evaluated the data quality
of a 25–b-value IVIM protocol in patients with malignant liver lesions and normal
liver tissue as a standard of reference, (2) calculated an optimal b-value distribution
and compared with the standard of reference, and (3) compared the 25–b-value
protocol with other proposed protocols in the literature.
Materials andMethods: Intravoxel incoherent motion imaging with 25 b-values
was performed at 3 T in a total of 15 patients with malignant liver lesions. Refer-
ence IVIM parameter maps were calculated in tumor and normal liver tissue.
With these parameters, optimal IVIM protocols with reduced numbers of b-values
were calculated. These optimal IVIM protocols were again applied to calculate
new IVIM parameter maps that were compared with the reference parameter
maps by calculating mean relative errors. In addition, 35 other IVIM protocols,
as found in literature, were compared in a similar way with the 25–b-value pro-
tocol serving as a standard of reference.
Results: Themean relative error depends on the number of b-values and their dis-
tribution. In tumor tissue, the error is higher and more variable than in normal-
appearing liver tissue. The largest errors occur in tumor tissue and in the protocols
having low numbers of b-values in the IVIM protocols. In the calculated optimal
IVIMprotocols, themean relative errors decreased by 40%ormorewhen the number
of b-values included increased from 4 to 16. The mean relative errors in the pro-
tocols adapted from the literature vary substantially between the various b-value
distributions. One optimized 16–b-value protocol, which was found in literature,
reduced the average relative error by 80%when compared with 4– and 5–b-value
protocols listed in literature.
Conclusions: Including more b-values and applying an optimized b-value distri-
bution significantly reduces errors in the IVIM parameter estimates, thereby in-
creasing its accuracy.
This effect is even more pronounced in inhomogeneous tumor compared
with that in normal liver tissue. However, when restrictions in acquisition time or
patient-related factors apply, a minimum of 16 b-values should be considered for
reliable results.
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(Invest Radiol 2016;00: 00–00)
M agnetic resonance (MR) diffusion-weighted imaging (DWI) is avery successful and widely used functional imaging protocol pro-
viding information about the mobility of water molecules in tissue. By
changing the amount of diffusion weighting, the b-value, it can be made
more sensitive to smaller or larger displacements, such as, for example,
in diffusion and perfusion, respectively.
Until recently, the DWI scan protocol was mainly applied to vi-
sualize the molecular water diffusion by scanning images with high-
diffusion weighting (b-values >150 s/mm2). The diffusion coefficient
D, representing the true molecular water diffusion, can be obtained
by fitting the b-values and corresponding measured data to a simple
monoexponential diffusion model (Supplemental Digital Content 1,
http://links.lww.com/RLI/A221). Because the diffusion is usually
restricted in tissue, the diffusion coefficient is also known as the appar-
ent diffusion coefficient.
Where “conventional” DWI is a method to visualize the molec-
ular water diffusion only, intravoxel incoherent motion (IVIM) imag-
ing is a method to visualize both the molecular water diffusion and
the information about the microcirculation by using high and low
b-values. The proposed biexponential IVIM model was described by
Le Bihan et al1,2:
S bð Þ = S 0ð Þ ¼ 1 − fð Þ  exp −bDð Þ þ f  exp −b Dþ D*½ ð Þ ðEq: 1Þ
where f is the fraction of the perfusion component and D* is the pseu-
dodiffusion coefficient, related to perfusion in the microcirculation.
Intravoxel incoherent motion is becoming more and more pop-
ular in clinical research as it provides the additional perfusion infor-
mation without the need of extensive changes in the MR acquisition
protocols.3–6 The IVIM model is, however, less stable than the mono-
exponential diffusion model, as it requires the fitting of more variables.
One of the major concerns when implementing an IVIM pro-
tocol is the optimal number and distribution of b-values. In theory, 4
b-values would be sufficient to fit a biexponential function7; however,
including more b-values would make the fit process more robust and
enables estimates of parameter uncertainties or quality. This could espe-
cially be important for reliable diagnoses and in cases where errors are
expected due to, for example, noise, or patient, for example, respiratory
and/or cardiac motion.8,9
Previously, other studies have investigated potentially optimal
b-value distributions.10–14 Lemke et al,15 for example, performedMonte
Carlo simulations to find the optimal b-value distributions in tissuewith
low (brain), medium (kidney), and high (liver) IVIM perfusion. How-
ever, in clinical cases, the chosen optimal b-value distributions may
not perform as one would expect due to, for example, different IVIM
parameter ranges in healthy and inhomogeneous tumor tissue.
The aims of this work were (1) to test and evaluate the data qual-
ity of a 25–b-value IVIM protocol in patients with malignant liver
lesions and normal liver tissue as a standard of reference, (2) to calculate
an optimal b-value distributions and compare to the standard of refer-
ence, and (3) to compare the 25–b-value protocol with other proposed
protocols in the literature concerning data quality.
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MATERIALS AND METHODS
Patients
Between September 2012 and January 2014, a total of 15 con-
secutive patients (mean age, 63 years; range, 33–88 years; 7 women,
8 men) with malignant liver lesions participated in this study. All in-
cluded patients were referred clinically to our center for PET/CT for ei-
ther staging or restaging/follow-up of various malignant tumors and
volunteered to receive an additional MR imaging (MRI) examination.
Exclusion criteria were contraindications to MRI, such as severe claus-
trophobia, andMRI-incompatible implants, such as cardiac pacemakers,
insulin pumps, or neurostimulators. This prospective study was ap-
proved by the institutional review board and by the cantonal ethics com-
mittee. Signed informed consent was obtained from each patient before
the inclusion into this study. Parts of this patient population have been
evaluated in other studies in a different context.
Magnetic Resonance Imaging
All MRI examinations were performed on a 3.0-T whole-body
MR system (Discovery 750wMR;GEHealthcare,Waukesha,WI) using
the body coil for excitation and a posterior and anterior coil array for
signal reception.
After conventional T1- and T2-weighted imaging, IVIM imaging
was performed using a 2-dimensional diffusion-weighted spin-echo
single-shot echo-planar imaging sequence covering 8 to 19 slices cen-
tered on the lesion of interest. Parallel imaging, array spatial sensitivity
encoding technique, was applied to reduce image distortion.
Three different protocols, A, B, and C, were applied, but only 1
in each patient. The acquisition parameters are listed in Table 1. The
IVIM acquisitions consisted of 25 b-values or diffusion weightings, in-
cluding b = 0 s/mm2. The 3 orthogonal gradient directions were applied
simultaneously (3 in 1). This large set of b-values was chosen to have
a good representation of all signal values in the interval from b = 0 to
800 or 1000 s/mm2 and still have reasonable imaging times to avoid ex-
tensive patient discomfort. Patients continued normal breathing during
the acquisition and respiratory gating was applied.
Image Processing
Intravoxel incoherent motion parameter mapswere calculated by
voxelwise fitting the model of equation 1 to the measured, 25 b-values,
data using Matlab 2013b (MathWorks, Natick, MA). The applied
method is a nonlinear least squares fit using a trust region algorithm.16
The IVIM parameters f,D, andD*were allowed to vary in the reference
ranges found in liver and tumors. The boundaries were set to 1.0 10−6
and 0.6 for f, 0.01 10−3 mm2/s and 3.2 10−3 mm2/s for D, and 1
10−3 mm2/s and 500  10−3 mm2/s for D*. The initial value for f was
set to 0.2, and the initial value of D was set to the estimated diffusion
calculated before by fitting the high b-values (>100 s/mm2) to a simple
monoexponential diffusion model (Supplemental Digital Content 1,
http://links.lww.com/RLI/A221). The initial value of D* was set to
10 times D.
Using PMOD v3.5 (PMOD Technologies, Zurich, Switzerland),
the regions of interest (ROIs) were manually drawn on the b = 0 s/mm2
IVIM images around the malignant lesions in the liver on all slices with
a visible malignant lesion by a researcher with 5 years of experience.
In addition, ROIs with a diameter of approximately 30 mmwere drawn
in normal-appearing liver tissue, avoiding large vessels and ducts. The
ROIs were copied to the IVIM parameter maps, and the voxel values
for f, D, and D* were extracted to calculate arithmetic means for every
ROI. The ROIs were grouped according to tumor or normal tissue type
and the minimal; maximal as well as the arithmetic mean and standard
deviation were calculated for all IVIM parameters for each group.
Calculation of Optimal b-Value Distributions
Reducing the number of diffusion weightings reduces scan time,
patient discomfort, and finally acquisition costs. Therefore, new b-value
distributions with less than 25 b-values were calculated to find opti-
mal distributions with less b-values and results comparable to the 25–
b-value distribution. To find these optimal b-value distributions, the
b-values that minimized the error propagation factor ε for the bi-
exponential model were selected. The error propagation factor was cal-
culated in a similar way as described by Zhang et al12 (Supplemental
Digital Content 2, http://links.lww.com/RLI/A222). The previously
TABLE 1. IVIM Acquisition Parameters
Protocol A Protocol B Protocol C
TE, ms 69.1–69.3 71.4–71.7 64.2–68.4
TR, ms 4286–6000 4286 3157.9–7500
Flip angle, degrees 90 90 90
No. averages
b = 0 s/mm2 1 1 1
b = 10–200 s/mm2 4 4 2 or 4
b = 250–1000 s/mm2 1 1 1
Acquisition matrix 128  96 160  128 160  128
Image size 256  256 256  256 256  256
Reconstruction
diameter, mm
400 400 400
Pixel size, mm 1.6  1.6 1.6  1.6 1.6  1.6
Slice, mm 8 8 8–10
Parallel imaging ASSET ASSET ASSET
Bandwidth, Hz 1953 1953 1953
Slices 11–14 9–10 8–19
b-values
(s/mm2, n = 25)
0, 15, 30, 45, 60, 75, 90, 110, 130, 150,
170, 185, 250, 300, 350, 400, 450, 500,
550, 600, 650, 700, 750, 800, 1000
0, 13, 25, 38, 50, 63, 75, 88, 100, 113,
125, 138, 150, 163, 175, 188, 200, 300,
400, 500, 600, 700, 800, 900, 1000
0, 10, 20, 30, 40, 50, 60, 70, 80, 90,
100, 110, 120, 130, 140, 150, 160, 170,
180, 190, 200, 350, 500, 650, 800
IVIM indicates intravoxel incoherent motion; ASSET, array spatial sensitivity encoding technique; TE, Echo Time; TR, Repetition Time.
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described minimal and maximal f, D, and D* values, obtained with the
25–b-value distribution, were inserted as the typical parameter ranges
for the calculation of the error propagation factor. For the optimization,
the parameter ranges for tumor and normal liver tissue were combined.
Because of the long computational time, it is almost impossible
to test all possible b-value combinations within a reasonable time. To
circumvent this problem, the b-values were limited to the 25 b-values
previously defined, and we started with an initial set of 4 b-values, as
this is the minimum amount of b-values needed to fit the biexponential
function. This set of initial b-values was then extended with b-values
that continued to minimize ε.
All possible combinations of 4 b-values, which included the
minimum (b = 0 s/mm2) and the maximum (b = 800 or 1000 s/mm2),
were evaluated. The combination that minimized ε was chosen as the
optimal 4–b-value distribution. The optimal 5–b-value distribution
was obtained by adding 1 b-value to the optimal 4–b-value distribution.
The added b-value should again result in a new combination with min-
imal ε. This process was repeated until we achieved 22 optimal b-value
distributions with 4 to 25 b-values.
Distributions of b-Values in the Literature
and Comparison
After calculation of these “optimal” b-value distributions, 35
empirically chosen, different b-value distributions, as found in litera-
ture, were included for comparison. The preferred distributions were
IVIM liver tumor protocols covering the range from 4 to 25 b-values.
In case the preferred distributions were not available in literature, abdo-
minal IVIM protocols with a b-value range between 0 and 1000 s/mm2
were preferably selected. For comparison, several IVIM protocols
intended for other tissues were added (Supplemental Digital Content 3,
http://links.lww.com/RLI/A223).7,10,11,15,17–31 The literature-based
b-values were mapped to the nearest b-values available in the measured
standard of reference 25–b-value data sets.
The work by Lemke et al15 was also included as many groups
refer to their article and use their recommendations for b-value distribu-
tions. They list 3 types of tissue comparable with low (brain), medium
(kidney), and high (liver) IVIM perfusion, and the b-value range
(0-1000 s/mm2) is comparable with other (liver) studies included in this
work. Lemke presented multiple b-value distributions, some of them
having duplicate b-values in 1 distribution. Only the unique b-values
and b-values near the measured 25 b-values were selected in this re-
search to avoid mapping problems. This evaluation has been taken as
one of the literature references since it is one of the very few studies try-
ing to find the optimal b-value distribution and evaluating these distri-
butions, with up to 16 b-values, in healthy volunteers.
Error Calculations
The calculated optimal b-value distributions, the mapped b-value
distributions from literature, and their corresponding measured signals
were used to calculate new IVIM parameter maps by fitting the model
of Equation 1 to the data, in the same way as described before with the
25–b-value distribution. The f,D, andD* voxel values in the ROIs were
again extracted and compared with the values that were previously cal-
culated using the 25–b-value distribution. The relative mean absolute
error γ in each ROI was then calculated with:
γx ¼
1
N ∑
N
i¼1 Xi−Xi;ref




Xref
ðEq: 2Þ
where X is 1 of the 3 parameters f,D, orD*,N is the number of voxels in
the ROI, Xi is the fitted result in a voxel in the ROI, Xi,ref is the fitted
result in the corresponding voxel in the 25–b-value based reference,
and X ref is the arithmetic mean of all Xi,ref in the ROI. Voxels with fref <
10−4, D*ref < 10
−5 mm2/s, or Dref < 10
−6 mm2/s were excluded.
The calculated relative errorswere grouped together according to
tissue type and number of b-values or literature protocols, and arith-
metic means and standard deviations were calculated for each group.
RESULTS
In protocol group A, 4 patients were scanned. One patient had
no or very small tumors (<15 mm diameter) and was excluded for the
lesion analysis. One patient was included after radiotherapy and had
2 metastases from melanoma that were both included. The 2 other pa-
tients had lesions from breast cancer and a metastatic melanoma with-
out treatment. In protocol group B, 5 patients were scanned. One
patient had 2 very large colon metastases in the liver and was excluded
for the normal liver tissue analysis as no large enough region could be
identified as normal liver. Two patients had no or very small tumors
(<15 mm diameter), and 1 patient had motion artifacts; all were ex-
cluded for the lesion analysis. One patient had 2 metastases from pri-
mary bronchial lung carcinoma, and both were included. In protocol
group C, 6 patients were scanned. Two patients had no or very small tu-
mors (<15 mm diameter), and 1 patient had motion artifacts; all were
excluded for the lesion analysis. The other 3 patients had metastases
from primary cholangiocarcinoma, colon cancer, and pancreatic cancer.
Of these, the first patient was scanned before therapy, the latter 2 after
chemotherapy.
Overall, 14ROIs (median size, 277 voxels; range, 277–807 voxels)
of normal liver tissue and 11 ROIs (median size, 422 voxels; range, 50–
4624 voxels) within malignant liver lesions were evaluated.
Examples of the IVIM parameter maps are shown in Figure 1.
Differences in the perfusion fraction (f), the pseudodiffusion (D*),
and the diffusion (D) maps, when calculated with 4–, 9–, and 25–b-value
distributions, can clearly be appreciated.
The minimal, maximal, arithmetic mean, and standard deviation
for f, D, and D* in tumor and normal liver tissue, calculated with the
25–b-value data sets, are listed in Table 2.
Calculation of Optimal b-Value Distributions
Optimal parameter distributions for the 3 protocols A, B, and C
were calculated by inserting the previously evaluated minimal andmax-
imal values for f,D, andD* (Table 2) in the cost function of Zhang et al.
The resulting b-value distributions are shown in Table 3.
These optimal parameter distributions were tested by calculating
the relative errors γ, and the results are shown in Figure 2. It shows the
mean relative error γ for all the calculated optimal b-value distributions
with 4 to 25 b-values. In both, normal liver tissue and tumor tissue, a
clear trend of decreasing mean relative error can be observed when
the number of b-values increases. The mean relative error in tumor tis-
sue is somewhat higher and more variable than in normal-appearing
liver tissue. The largest errors occur in the pseudodiffusion, D*, espe-
cially in tumor tissue and in the range where there are low numbers of
b-values in the distributions. The mean relative errors for 4 b-values
are 0.51 for f, 2.08 for D*, and 0.36 for D in tumor and 0.40 for f,
0.98 forD*, and 0.45 forD in the normal liver tissue. The mean relative
errors for 16 b-values are 0.29 for f, 0.52 forD*, and 0.18 forD in tumor
and 0.19 for f, 0.33 for D*, and 0.14 for D in the normal liver tissue.
The mean relative errors decreased by 40% or more when the number
of b-values included increased from 4 to 16.
Distributions of b-Values in Literature and Comparison
The mean relative errors for the modified and mapped b-value
distributions by Lemke et al,15 shown in Figure 3, display a similar de-
creasing trend as the calculated optimal b-value distributions when
more b-values are included. The mean relative errors for 4 b-values
are 0.42 for f, 3.02 for D*, and 0.26 for D in tumor and 0.41 for f,
2.19 forD*, and 0.44 forD in the normal liver tissue. The mean relative
errors for 16 b-values are 0.18 for f, 0.47 forD*, and 0.17 forD in tumor
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FIGURE 1. Example of IVIM parameter maps calculated with (A) 4– (far left column; Döpfert et al7), 9 (left column; Cohen et al10), 16– (right column;
Wurnig et al17), and 25– (right column; reference) b-value distributions; (B) optimal 4– (far left column), 9– (left column), 16– (right column), and
25– (far right column) b-value distributions. The top row shows an axial unweighted (b = 0 s/mm2) DWI image with a liver lesion. The liver lesion ROI is
indicated by a white line in all images. The second row shows the perfusion fraction (f) maps, the third row shows the pseudodiffusion (D*) maps, and
the bottom row shows the diffusion (D) maps. The map images only show the area containing the liver lesion ROI. The maps clearly show differences
when calculations are performed with less b-values, and they also show that the tissue inside the ROI is inhomogeneous. The optimal 4– and 9–b-value
distributions perform better than the corresponding literature distributions. However, in this liver lesion, the 16–b-value distribution by Wurnig et al
performs better than the optimal 16–b-value distribution. Figure 1 can be viewed online in color at www.investigativeradiology.com.
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and 0.14 for f, 0.22 for D*, and 0.15 for D in the normal liver tissue.
This means that the relative errors decreased by 35% or more when
the number of b-values included increased from 4 to 16.
The mean relative errors in the protocols adapted from the liter-
ature (Fig. 4) vary substantially between the various b-value distribu-
tions. The mapped 11–b-value distribution by Leporq et al21 performs
clearly better than the mapped 9–b-value distribution by Klauss et al,26
whereas the 6 b-values between 100 and 800 s/mm2 are the same in
both cases. The differences are mainly found in the lower b-value range
where the former has 2more b-values. The protocols byHiepe et al19 and
Ichikawa et al20 have a relative higher number of lowb-values (<100 s/mm2).
These protocols also have lower errors in the pseudoperfusion D*.19,20
The 16–b-value distribution by Wurnig et al,17 which is taking
into account the findings of Lemke et al,15 performs best of the b-value
distributions found in literature with mean relative errors of 0.18 for f,
0.61 for D*, and 0.16 for D in tumor and 0.16 for f, 0.28 for D*, and
0.16 for D in normal liver tissue. It reduces the average error by 80%
when compared with the 4– and 5–b-value protocols. Figure 4 also
shows that, on average, the mean relative error is larger in liver tumor
tissue compared with that in normal liver tissue for f and D*, whereas
for D, the mean relative error is larger in normal liver tissue.
DISCUSSION
Although IVIM becomes more and more popular, there is cur-
rently no clear consensus on the number and distribution of b-values
to use. In this study, we acquired a rather extensive 25–b-value IVIM
protocol as a standard of reference to evaluate the data quality of other
IVIM protocols having less b-values. The evaluation was performed for
normal liver tissue and for malignant liver lesions. We showed that
IVIM data quality improves significantly when the number of b-
values included in the protocol is increased, making IVIM modeling
more robust.
The clinical role of IVIM is yet not completely defined, but there
is certainly great potential in clinical routine applications. Because there
is proof that multiparametric imaging can improve diagnostic accu-
racy,32,33 there is large interest to explore the possibilities of already
available techniques, for example, diffusion sequences. Because IVIM
is not only able to measure diffusion but also the microperfusion, it
could provide additional information concerning the tumor's oxygena-
tion status before therapy. This is important in scenarios where, for ex-
ample, antiangiogenic therapy is planned or, vice versa, tumor perfusion
is first therapeutically enhanced to ensure adequate delivery of che-
motherapy to the tumor. However, before such therapy decisions can
be based on imaging-derived parameters, it has to be ensured that data
quality is sufficient, measurements are highly reliable, and patient-
based influences are kept to a minimum.
Early IVIM studies usually evaluated a limited amount of up to
8 b-values and are likely chosen empirically. Having a limited num-
ber of b-values increases the risk of higher errors as, for example, 1 out-
lier already could have a large effect on the model fitting procedure and
thus on the resulting IVIM parameters. Conversely, obtaining more than
the minimal required 4 b-values for IVIM requires more scan time, and
too extensive MR protocols may increase patient discomfort, which
could again lead to patient motion and thus acquisition errors. There-
fore, the clinically acceptable imaging time for IVIM was limited to
5 to 6 minutes in our study. In these 5 to 6 minutes, we were able to
acquire a 25–b-value IVIM reference scan protocol. With these 25
b-values, we have significantly more data points available for the fitting
procedure than the average 4– to 16–b-value IVIM protocols listed in
literature. This allows us to use it as a reference in the comparison with
other IVIM protocols.
Scanning an extensive 25–b-value IVIM protocol is not always
desirable or even possible. For homogeneous tissue, when the expected
IVIM parameter ranges are small and known beforehand, one could cal-
culate and apply an optimal IVIM protocol with a reduced number of
b-values and still would have sufficient data quality. A number of stud-
ies were dedicated on finding optimal b-value distributions: for exam-
ple, Dyvorne et al14 evaluated optimized b-value distributions in the
liver for subjects enrolled in a liver fibrosis study. Although this study
was also performed in the liver, the tissue properties (perfusion and dif-
fusion) in tumors are different compared with that in (malignant) liver
lesions. Jambor et al13 determined the optimal b-value distribution for
healthy prostate tissue with b-values up to 2000 s/mm2. However, for
prostate imaging, usually higher b-values are applied.
Zhang et al12 optimized the b-value sampling for a biexponential
DWI model of the kidney, and Lemke et al15 optimized the b-value dis-
tributions in tissue for low (brain), medium (kidney), and high (liver)
IVIM perfusion. The studies by Jambor et al, Zhang et al, and Lemke
et al were, however, validated in healthy volunteers. Tumorous tissue
is known to be more inhomogeneous based on distorted cell conglom-
erates and partially inadequate blood supply and is therefore partially
composed of necrotic tissue. Thus, the microperfusion and diffusion
characteristics are significantly different compared with that in normal
TABLE 2. The Calculated IVIM Parameters f, D, and D* Using 25 b-Values
Tumor Normal Liver
f, % D, 10−3 mm2/s D*, 10−3 mm2/s f, % D, 10−3 mm2/s D*, 10−3 mm2/s
Minimum* 13 0.46 5.26 19 0.43 24.6
Maximum* 58 1.98 123.0 43 1.13 278.8
Mean (SD)* 32 (13) 1.24 (0.45) 55.0 (36.4) 30 (6.8) 0.83 (0.18) 124.4 (84.5)
*The values are minimum, maximum, and mean (SD) of the mean ROI voxel values.
IVIM indicates intravoxel incoherent motion.
TABLE 3. Optimal b-Value Distributions for Protocol A, B, and C
Initial
b-Values, s/mm2 Added b-Values, s/mm2
Protocol A 0, 15, 170, 1000 800, 45, 750, 700, 60, 650, 250, 75,
600, 90, 550, 500, 30, 110, 450,
130, 400, 150, 350, 185, 300
Protocol B 0, 13, 175, 1000 800, 50, 900, 700, 63, 600, 75, 500,
163, 38, 400, 88, 300, 25, 100, 113,
125, 200, 138, 188, 150
Protocol C 0, 20, 150, 800 650, 50, 10, 500, 60, 350, 70, 40, 200,
80, 30, 190, 90, 180, 100, 170, 110,
120, 160, 130, 140
For the optimization, the parameter ranges for tumor and normal liver tissue
(Table 2) were combined.
Investigative Radiology • Volume 00, Number 00, Month 2015 Protocol Evaluation and IVIM Data Quality
© 2015 Wolters Kluwer Health, Inc. All rights reserved. www.investigativeradiology.com 5
                                            Copyright © 2015 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.                                               
                                 This paper can be cited using the date of access and the unique DOI number which can be found in the footnotes.
tissue. Consequently, the expected IVIM parameters and their ranges
are different in pathologic lesions, and the presented optimal distribu-
tions may no longer be optimal for these cases and errors may increase.
Because the diffusion coefficient is more related to the high b-
values, tissue with a high diffusion coefficient could need more b-values
in this region and/or more signal averages to increase signal to noise
ratio and measured accuracy for a more reliable fit, although the error
in the diffusion estimation is usually relatively low compared with that
in the pseudodiffusion constant, which is approximately 2 to 3 times higher
(Figs. 2, 3). The pseudodiffusion constant is more related to the low
FIGURE 2. The mean relative errors γ in the IVIM parameters for the optimal b-value distributions calculated with a cost function by Zang et al12:
(A) the error in the perfusion fraction, f’; (B) the error in the pseudodiffusion, D*; (C) the error in the diffusion, D. From left to right in each figure, an
increasingnumberofb-values, indicatedbythenumbernexttothehorizontalaxis.Ontherightsideofeverygraphisthereferencewith25b-values,whichshouldhave
amean relative error of zero. The light green bars indicate the errors in the tumor tissue, the dark green bars indicate the error in the normal-appearing
liver tissue, and std is the standard deviation of the relative error. Figure 2 can be viewed online in color at www.investigativeradiology.com.
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b-values. This corresponds to the steep part in the measured signal versus
b-value graph (Supplemental Digital Content 4, http://links.lww.com/
RLI/A224). This part is more difficult to fit reliably, especially in
tissue with a high perfusion factor. Protocols with a relative
higher number of low b-values, such as that of Ichikawa et al and
Hiepe et al, have a lower relative error for the pseudodiffusion D*
(Fig. 4).19,20 More parameter considerations can be found in
Supplemental Digital Content 5, http://links.lww.com/RLI/A226.
Overall, the diffusion parameterD has the smallest relative error,
followed by the perfusion fraction f and the pseudodiffusion D*. The
FIGURE 3. Themean relative errors γ in the IVIMparameters for the b-value distributions by Lemke et al15: (A) the error in the perfusion fraction, f; (B) the
error in the pseudodiffusion, D*; (C) the error in the diffusion, D. From left to right in each figure, an increasing number of b-values indicated by the
number next to the horizontal axis. On the right side of every graph is the reference with 25 b-values, which should have amean relative error of zero. The
light green bars indicate the errors in the tumor tissue, the dark green bars indicate the error in the normal-appearing liver tissue, and std is the standard
deviation of the relative error. Figure 3 can be viewed online in color at www.investigativeradiology.com.
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FIGURE 4. The mean relative errors γ in the IVIM parameters for the b-value distributions found in literature (see also Supplemental Digital Content 3,
http://links.lww.com/RLI/A223): (A) the error in the perfusion fraction, f; (B) the error in the pseudodiffusion, D*; (C) the error in the diffusion, D. From
left to right in each figure, an increasing number of b-values, indicated by the number next to the horizontal axis. On the right side of every graph is the
reference with 25 b-values, which should have a mean relative error of zero. The light green bars indicate the errors in the tumor tissue, the dark green
bars indicate the error in the normal-appearing liver tissue, and std is the standard deviation of the relative error. The figure does not show a quality
measure for the work performed by the listed researchers. Included protocols may not have been intended for IVIM on malignant liver lesions and are
only added for comparison. Figure 4 can be viewed online in color at www.investigativeradiology.com.
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latter is usually worst with the largest relative error. Similar results
are reported in literature for different scanning and fitting methods
and tissues.12,14,15,21,34,35
The largest gain in error reduction is in the range when moving
from 4 to 11 b-values (for example, see Figs. 2, 3). Therefore, wewould
consider 11 b-values an absolute minimum. These findings are similar
to previous work by Lemke et al and Jambor et al in healthy liver, kid-
ney, and spleen.13,15 Dyvorne et al14 on the other hand recommended a
minimum of 4 b-values for their liver fibrosis study. TheirD* reproduc-
ibility was, however, significantly worse compared with that of other
studies. The authors claim that this could be related to the wider param-
eter range they allowed in their study. If the expected IVIM parameter
range is very small, an optimized protocol could reduce the number
of b-values even further. However, in tumor tissue, a larger parameter
range is expected, and therefore more b-values need to be included.
With 16 b-values, the error is reduced even further (see also
Figs. 2, 3) while the acquisition time is still reasonable.With the optimal
calculated b-value distributions we, for example, showed that the mean
relative error in normal liver tissue is less than 0.2 with 16 b-values
(Fig. 2). Therefore, we would recommend 16 b-values.
However, when analyzing inhomogeneous tumor tissue with the
same reduced amount of (optimized) b-values, the mean relative error
increased to 0.5. The results in Figure 3 show that (the mapped versions
of ) the distributions proposed by Lemke et al are comparable to our
optimized distributions and also have an increased error in tumor tis-
sue compared with that in normal liver tissue. Therefore, when analyz-
ing (inhomogeneous) tumor tissue, or multiple organs, large differences
in IVIM parameters and reduced data quality have to be expected.
These wide ranges in expected IVIM parameters make it hard to find
optimal b-value distributions. In these cases, it recommends scanning
as many b-values as time permits.
Although not all protocols available in the literature comparison
were intended for IVIM or liver tumor analysis (Supplemental Digital
Content 3, http://links.lww.com/RLI/A223), the results, presented in
Figure 4, show that a suboptimal choice of b-values could lead to large
errors. For example, the mapped protocols by Patel et al, Klauss et al,
Lee et al, and Cohen et al all have 9 b-values, but the latter has the
smallest mean relative errors. It even performs better than the mapped
11–b-value protocol by Leporq et al. The mapped 16–b-value distri-
bution by Wurnig et al17 performs best of the 20 literature cases. It is
taking into account the findings of Lemke et al,15 meaning that a useful
b-value distribution should have more b-values in the 0 to 50 s/mm2
range and less in the midrange of 450 to 800 s/mm2 in a distribution
up to 1000 s/mm2.
As mentioned previously, motion could play an important role in
abdominal imaging. The larger relative error in tumor tissue compared
with that in normal-appearing tissue could also be partially explained by
motion and partial volume. Respiratory motion and cardiac and aortic
pulsations cause the position of the tumor to change during scanning.36
As a result, surrounding liver tissue could move in and out of the tumor
ROIs and, in addition, because tumor tissue is often less homogeneous
than liver tissue, motion in a tumor ROI could have a larger effect than
motion inside a normal liver ROI when comparing IVIM parameter
maps. Respiratory and cardiac gating could circumvent this problem,
but it would roughly double the total IVIM acquisition time. Increasing
the number of signal averages could improve the results, but often only
by blurring the motion artifact. A better solution could be scanning du-
plicate b-values and rejecting data points that are affected by motion
during postprocessing. This way, the increased scan time could lead
to an increase in signal to noise, of course depending on the amount
of data points that are not rejected. Instead of rejecting data points,
one could also perform motion correction. As the high b-value images
have only a limited amount of signal and are therefore difficult to reg-
ister, one could scan in a different way, for example, alternating low
b-value with high b-value scans.37
Our study has some limitations. Repeatedly adding b-values to a
set of optimal b-values does not necessarily lead to the best b-value set
with the lowest cost. Testing all possible b-value combinations would be
better; however, such computations are almost impossible due to the
very high number of possible combinations. In addition, the mapping
of the b-values, as found in literature, to the nearest b-value in our
25–b-value IVIM protocol could have an effect on the mean relative er-
ror, although the effect is expected to be minimal.
CONCLUSIONS
Including more b-values and applying an optimized b-value dis-
tribution significantly reduces errors in the IVIM parameter estimates,
thereby increasing its accuracy.
This effect is even more pronounced in inhomogeneous tumor
compared with that in normal liver tissue. However, when restrictions
in acquisition time or patient-related factors apply, a minimum of 16
b-values should be considered for reliable results.
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